Reynolds-MacKenzie joins Open Health

July 15, 2011
Medical Communications medical communications agency, medical communications news

Specialist health agency Reynolds-MacKenzie has become the latest recruit to the Open Health stable, bolstering the new communications group’s PR …

The changing fortunes of NICE and health secretaries

July 15, 2011
Sales and Marketing NICE

You might not have noticed, but the government has performed a major U-turn. No, I don’t mean the NHS reform …

UK pricing reform derailed

July 15, 2011
Sales and Marketing NICE, PPRS, value-based pricing

Plans to revolutionise the pricing of medicines in the UK look to be another casualty in the Department of Health’s …

Doctors and social media

Digital Pharma: Facebook warning for UK doctors

July 14, 2011
Medical Communications BMA, Digital Pharma blog, doctors, nurses, social media

UK doctors have been told not to accept patients as Facebook friends in order to maintain professional boundaries. The BMA’s …

European approval for BMS skin cancer vaccine

July 14, 2011
Sales and Marketing BMS, Yervoy, ipilimumab

Bristol-Myers Squibb’s skin cancer vaccine Yervoy has been approved in Europe after showing survival benefits in one of the most …

France cleans up regulation – and restricts pharma role

July 14, 2011
Research and Development, Sales and Marketing France, Mediator, Servier, pharmacovigilance, research and development news

France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …

Spain’s austerity sees pharma market shrink by €2 billion

July 14, 2011
Sales and Marketing Spain, healthcare costs

Spain’s pharma industry has hit out against the drastic budget cuts the government introduced last year, saying they’ve led to …

Market access and the new consortia

July 14, 2011
Sales and Marketing GP consortia, NHS reform, market access

The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …

Paul Barrow joins CiToxLAB

July 14, 2011
Research and Development appointment, research and development

French CRO CiToxLAB has appointed Paul Barrow as director of scientific projects and client consulting. He joins the Evreux-based company, …

Newcastle GP consortia

What now for GP consortia?

July 13, 2011
Sales and Marketing GP consortia, NHS reforms

David Cameron unveiled major changes to the direction of the health reforms on 8 June – and in doing so, …

Sanofi eyes phase III move for sarilumab in rheumatoid arthritis

July 13, 2011
Research and Development Regeneron, Sanofi, ankylosing spondylitis, research and development news, rheumatoid arthritis, sarilumab

Sanofi is poised to move sarilumab into phase III trials for rheumatoid arthritis after the monoclonal antibody showed positive results …

US Food and Drug Administration

Pharma regulators consult on drug development initiatives

July 13, 2011
Research and Development Companion Diagnostics, EMA, FDA, Pharmacogenomics, biomarkers, research and development news

Pharma regulators in the US and Europe have put out separate consultations on issues affecting how medicines are developed. The …

Amgen

Amgen collaborates on cancer antibody research

July 13, 2011
Research and Development Amgen, Cancer, TGF-beta monoclonal antibody, research and development news

Amgen has teamed up with German biotech Micromet to develop tumour-destroying antibodies in a two-year deal that could net Micromet …

clavis_pharma_nicholas_adams

Clavis Pharma appoints Nicholas Adams

July 13, 2011
Research and Development appointment, research and development

Norwegian cancer drug development company Clavis Pharma has appointed Nicholas Adams as chief business officer. He has more than 23 …

Kantar Health Launches Global Health and Wellness Quarterly Update

July 12, 2011
Sales and Marketing Kantar Health, depression, emerging markets, information, newsletter, work productivity

The inaugural issue of Kantar Health’s Global Health and Wellness Update is now available. This is a quarterly newsletter sharing …

Sanofi's Multaq (dronedarone)

EMA widens safety review of Sanofi’s Multaq

July 12, 2011
Sales and Marketing Multaq, Sanofi

European regulators are to extend their assessment of the risks associated with Sanofi’s atrial fibrillation (AF) medicine Multaq to take …

Cellectis appoints Dr Andrew Scharenberg

July 12, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Paris-based genome engineering specialist Cellectis Therapeutics has appointed Dr Andrew Scharenberg as chief scientific officer. He is an attending physician …

EMA plans adverse event reports for the public

July 12, 2011
Research and Development, Sales and Marketing EMA, adverse events, patient information

The EMA will start producing monthly adverse event reports for the public as part of its plans to open up …

New $50m plant unveiled by Kyowa Hakko Kirin

July 12, 2011
Manufacturing and Production Kyowa Hakko Kirin, pharma manufacturing news

Japan’s Kyowa Hakko Kirin is to build a new manufacturing unit for oral formulations at its main production facility in …

OctoPlus wins Danish development, manufacturing contract

July 12, 2011
Manufacturing and Production OctoPlus, pharma manufacturing news

Dutch drug delivery specialist OctoPlus has been awarded a contract with an unidentified Danish drugmaker based on its microsphere technology. …

The Gateway to Local Adoption Series

Latest content